Search by Drug Name or NDC
NDC 68382-0223-06 atomoxetine 100 mg/1 Details
atomoxetine 100 mg/1
atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ATOMOXETINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.
Related Packages: 68382-0223-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atomoxetine
Product Information
| NDC | 68382-0223 |
|---|---|
| Product ID | 68382-223_f9e4c151-6cdd-4f22-9798-8b01dd940233 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | atomoxetine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | atomoxetine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | ATOMOXETINE HYDROCHLORIDE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079017 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0223-06 (68382022306)
| NDC Package Code | 68382-223-06 |
|---|---|
| Billing NDC | 68382022306 |
| Package | 30 CAPSULE in 1 BOTTLE (68382-223-06) |
| Marketing Start Date | 2017-06-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |